ERYTECH PHARMA

ERYTECH PHARMA (EPA:ERYP)

06/01/2021 22:30

ERYTECH to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference

Voir tous les communiqués de ERYTECH PHARMA

ERYTECH PHARMA (EPA:ERYP)

14/12/2020 22:30

ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Cancer

Voir tous les communiqués de ERYTECH PHARMA

ERYTECH PHARMA (EPA:ERYP)

10/12/2020 22:30

ERYTECH to Present at the JMP Securities Hematology Summit

Voir tous les communiqués de ERYTECH PHARMA

ERYTECH PHARMA (EPA:ERYP)

07/12/2020 08:00

ERYTECH Announces Positive Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia Presented at the American Society of Hematology Annual Meeting

Voir tous les communiqués de ERYTECH PHARMA

ERYTECH PHARMA (EPA:ERYP)

03/12/2020 22:30

ERYTECH Announces Conference Webcast to Discuss Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia to be Presented at the American Society of Hematology 2020 Annual Meeting

Voir tous les communiqués de ERYTECH PHARMA

ERYTECH PHARMA (EPA:ERYP)

06/08/2020 18:00

Monthly information related to total number of voting rights and shares composing the share capital – July 31, 2020

Voir tous les communiqués de ERYTECH PHARMA

ERYTECH PHARMA (EPA:ERYP)

10/07/2020 18:00

Monthly information related to total number of voting rights and shares composing the share capital – June 30, 2020

Voir tous les communiqués de ERYTECH PHARMA

ERYTECH PHARMA (EPA:ERYP)

25/06/2020 08:00

ERYTECH extends its cash horizon by implementing a convertible bond financing

Voir tous les communiqués de ERYTECH PHARMA

ERYTECH PHARMA (EPA:ERYP)

26/05/2020 22:00

Erytech’s Combined Shareholders’ Meeting

Voir tous les communiqués de ERYTECH PHARMA

ERYTECH PHARMA (EPA:ERYP)

06/05/2020 22:30

ERYTECH Provides Business Update and Reports Cash Balance at End of Q1 2020

Voir tous les communiqués de ERYTECH PHARMA

«
1
2
3
4
5
6
7
8
9
10
»